BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21502971)

  • 1. Treatment of refractory and recurrent Clostridium difficile infection.
    Surawicz CM; Alexander J
    Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):330-9. PubMed ID: 21502971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
    Weis S; John E; Lippmann N; Mössner J; Lübbert C
    Zentralbl Chir; 2014 Aug; 139(4):460-8. PubMed ID: 24132675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.
    Pant C; Sferra TJ; Deshpande A; Minocha A
    Eur J Intern Med; 2011 Dec; 22(6):561-8. PubMed ID: 22075280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium Difficile Infection from a Surgical Perspective.
    Kaiser AM; Hogen R; Bordeianou L; Alavi K; Wise PE; Sudan R;
    J Gastrointest Surg; 2015 Jul; 19(7):1363-77. PubMed ID: 25917533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the economics of treating Clostridium difficile infection.
    Mergenhagen KA; Wojciechowski AL; Paladino JA
    Pharmacoeconomics; 2014 Jul; 32(7):639-50. PubMed ID: 24807468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile: an update for the primary care clinician.
    Salkind AR
    South Med J; 2010 Sep; 103(9):896-902. PubMed ID: 20697321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
    Kelly CP
    JAMA; 2009 Mar; 301(9):954-62. PubMed ID: 19190304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent and severe Clostridium difficile infection.
    Keller JJ; Kuijper EJ
    Annu Rev Med; 2015; 66():373-86. PubMed ID: 25587656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of refractory or recurrent Clostridium difficile infection].
    Kim SW
    Korean J Gastroenterol; 2012 Aug; 60(2):71-8. PubMed ID: 22926117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
    Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
    World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection: epidemiology, risk factors and management.
    Ananthakrishnan AN
    Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):17-26. PubMed ID: 21119612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and Treatment of Clostridium difficile Enterocolitis.
    Kodadek LM; Lipsett PA
    Adv Surg; 2018 Sep; 52(1):29-42. PubMed ID: 30098619
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridium difficile: a reemerging pathogen.
    Calfee DP
    Geriatrics; 2008 Sep; 63(9):10-21. PubMed ID: 18763846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Clostridium difficile infection.
    Gerding DN; Muto CA; Owens RC
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S32-42. PubMed ID: 18177219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.